1. Home
  2. MBAI vs SINT Comparison

MBAI vs SINT Comparison

Compare MBAI & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.76

Market Cap

12.0M

Sector

N/A

ML Signal

N/A

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$2.80

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBAI
SINT
Founded
2004
1996
Country
Israel
United States
Employees
85
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
11.1M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
MBAI
SINT
Price
$1.76
$2.80
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
72.9K
24.8K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.45
EPS
N/A
N/A
Revenue
N/A
$1,018,000.00
Revenue This Year
N/A
$80.35
Revenue Next Year
N/A
$270.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$1.72
52 Week High
$3.92
$6.78

Technical Indicators

Market Signals
Indicator
MBAI
SINT
Relative Strength Index (RSI) 54.00 57.87
Support Level $1.38 $2.60
Resistance Level $1.89 $2.96
Average True Range (ATR) 0.19 0.19
MACD 0.01 0.06
Stochastic Oscillator 40.85 78.22

Price Performance

Historical Comparison
MBAI
SINT

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

Share on Social Networks: